The Demand for Global Viral Vector Vaccines Manufacturing Market is to Rise Around 18.19% of CAGR by 2027
“According to the new market research report published by Inkwood Research, the global viral vector vaccine manufacturing market is growing at a CAGR of 18.19% throughout the forecasting years of 2019-2027.”
“Browse 75 market Data Tables and 39 Figures spread over 300 Pages, along with an in-depth TOC on global viral vector vaccine manufacturing market forecast 2019-2027.”
Viral vector vaccines is a radical new approach to vaccination that uses live viruses to carry DNA to human cells. The vaccines carry the DNA of interest into a host cell for the production of antigenic proteins. The vaccines have advantages like specific delivery of genes to target cells, induction of robust immune responses and increased cellular immunity, efficient gene transduction. The rising prevalence of chronic diseases and veterinary diseases across the globe is propelling the demand for viral vector vaccine manufacturing market.
Promising results from clinical studies are progressing the demand for viral vector vaccines market globally
Many organizations performed clinical studies that have proved to be promising about the use of vector-based vaccines for gene therapy and vaccinations. The clinical trials have initiated investments for drug development and commercialization. Viral vector vaccines are safe as compared to many live-attenuated virus vaccines. Due to the rising number of clinical trials for the use of vector-based vaccines in cancer gene therapy, genetic diseases and vaccine development is predicted to evolve the market across the globe.
To learn more about this report, request a free sample copy
Multivalent viral vector vaccines are the highest adopted application in the global market
Multivalent viral vector vaccines are vaccines in which antigens from different strains of a single pathogen and combined in a single vector. The multivalent viral vector vaccines possess the property of various antigens that prove beneficial for preventing various diseases. Influenza-virus-based platforms or Rhabdovirus are some of the platforms addressing various antigens making multivalent vaccines the highest adopted application in the global market. The practice of manufacturing a vaccine by combining the number of antigens into a single vaccine has led to the growth of multivalent viral vector vaccines.
North America is the prime contributor in the global viral vector vaccine manufacturing market
The North America region was the highest contributor to the global market in 2018. The market in the region is primarily driven by rising clinical testing and increasing government funding in cancer research. Due to the high prevalence of genetic diseases and chronic diseases in the region, the government’s investment in gene-editing tools and research has increased especially in the U.S. and Canada. Additionally, ongoing research activities to develop new and advance vaccines for diseases like influenza and other infectious diseases is likely to boost the demand for the market in the coming years.
The market is growing at a rapid pace. The top players operating in the global market are Advance biotherapeutics Consultancy, Applied Veromics, Benitic Biopharma, Biovian, Boehringer Ingelheim GmBH, Ceva Corporate, GE Healthcare, ID Pharma Co. Ltd, Advance Bioscience Laboratories Inc., Batavia Biosciences, Biogen Idec, Brammer Bio, Cell & Gene Therapy Catapult, Cobra Biologics, and Janssen Pharmaceutical Inc. The players are focusing on various strategies for development such as mergers, acquisitions, partnerships, joint ventures and business expansions. The companies need to invest heavily in research and development, clinical tests and studies to have the edge over competitors and develop upgraded vaccines.
About Inkwood Research
Inkwood Research specializes in syndicated & customized research reports and consulting services. Market intelligence studies with relevant fact-based research are customized across industry verticals such as technology, automotive, chemicals, materials, healthcare, and energy; with an objective comprehension that acknowledges the business environments. Our geographical analysis comprises of North & South America, CEE, CIS, Middle East, Europe, Asia, and Africa.